ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breakthrough blood test could spot dangerous virus earlier in vulnerable transplant patients
Diagnosis CompletedThis study tested a new blood test designed to detect cytomegalovirus (CMV) infection in people who have received a stem cell transplant. Researchers looked back at stored blood samples from 60 transplant patients to see if the new test, which looks for a specific viral marker, w…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Ting YANG • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC
-
Diabetes pill may shield transplant patients from deadly immune attack
Prevention CompletedThis study tested if adding the diabetes medication sitagliptin to standard preventive drugs could better protect patients from a dangerous immune reaction called graft-versus-host disease (GVHD) after a stem cell transplant. It involved 190 adults with blood cancers who received…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Mar 30, 2026 14:32 UTC